Form 4 holding
Director
Inhibikase Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 1,460,000
- Estimated value
- $2,000,200
- Report date
- 21 Oct 2024
- Price
- $1.37
- Ownership
- Indirect
| Sym | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|